CorMedix Inc.
General ticker "CRMD" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $546.4M
CorMedix Inc. follows the US Stock Market performance with the rate: 52.4%.
Estimated limits based on current volatility of 3.0%: low 8.16$, high 8.67$
Factors to consider:
- Current price 64.0% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.00$, 5.08$]
- 2024-12-30 to 2025-12-30 estimated range: [1.95$, 4.92$]
Financial Metrics affecting the CRMD estimates:
- Negative: Non-GAAP EPS, $ of -0.92 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Operating cash flow per share per price, % of -17.80 <= 2.35
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Positive: -0.96 < Investing cash flow per share, $ of -0.34
Short-term CRMD quotes
Long-term CRMD plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.19MM | $0.07MM | $0.00MM |
| Operating Expenses | $29.63MM | $30.69MM | $48.96MM |
| Operating Income | $-29.44MM | $-30.62MM | $-48.96MM |
| Non-Operating Income | $-0.02MM | $0.34MM | $2.62MM |
| Interest Expense | $0.02MM | $0.03MM | $0.00MM |
| R&D Expense | $13.13MM | $10.68MM | $13.16MM |
| Income(Loss) | $-29.46MM | $-30.29MM | $-46.34MM |
| Taxes | $-1.25MM | $-0.59MM | $0.00MM |
| Profit(Loss) | $-28.21MM | $-29.70MM | $-46.34MM |
| Stockholders Equity | $62.80MM | $55.06MM | $70.14MM |
| Inventory | $0.00MM | $0.00MM | $2.11MM |
| Assets | $68.95MM | $62.04MM | $82.06MM |
| Operating Cash Flow | $-21.16MM | $-24.36MM | $-38.41MM |
| Capital expenditure | $1.43MM | $0.22MM | $0.33MM |
| Investing Cash Flow | $-9.13MM | $-3.71MM | $-17.06MM |
| Financing Cash Flow | $41.76MM | $17.90MM | $55.92MM |
| Earnings Per Share* | $-0.75 | $-0.74 | $-0.91 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.